IL158058A0 - Combination of a taxane and a cyclin-dependent kinase inhibitor - Google Patents

Combination of a taxane and a cyclin-dependent kinase inhibitor

Info

Publication number
IL158058A0
IL158058A0 IL15805802A IL15805802A IL158058A0 IL 158058 A0 IL158058 A0 IL 158058A0 IL 15805802 A IL15805802 A IL 15805802A IL 15805802 A IL15805802 A IL 15805802A IL 158058 A0 IL158058 A0 IL 158058A0
Authority
IL
Israel
Prior art keywords
taxane
cyclin
combination
kinase inhibitor
dependent kinase
Prior art date
Application number
IL15805802A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL158058A0 publication Critical patent/IL158058A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15805802A 2001-03-23 2002-03-22 Combination of a taxane and a cyclin-dependent kinase inhibitor IL158058A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27794801P 2001-03-23 2001-03-23
US30269201P 2001-07-05 2001-07-05
US33491601P 2001-12-04 2001-12-04
PCT/EP2002/004083 WO2002076484A2 (en) 2001-03-23 2002-03-22 Combination of a taxane and a cyclin-dependent kinase inhibitor

Publications (1)

Publication Number Publication Date
IL158058A0 true IL158058A0 (en) 2004-03-28

Family

ID=27402954

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15805802A IL158058A0 (en) 2001-03-23 2002-03-22 Combination of a taxane and a cyclin-dependent kinase inhibitor
IL158058A IL158058A (en) 2001-03-23 2003-09-22 Combination of a taxane and a cyclin-dependent kinase inhibitor

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL158058A IL158058A (en) 2001-03-23 2003-09-22 Combination of a taxane and a cyclin-dependent kinase inhibitor

Country Status (33)

Country Link
US (2) US20020182204A1 (ko)
EP (1) EP1372652B1 (ko)
JP (1) JP2004521140A (ko)
KR (1) KR100879712B1 (ko)
CN (1) CN1498107A (ko)
AR (1) AR034222A1 (ko)
AT (1) ATE395917T1 (ko)
AU (1) AU2002312815B2 (ko)
BR (1) BR0208221A (ko)
CA (1) CA2441441C (ko)
CY (1) CY1110449T1 (ko)
CZ (1) CZ301423B6 (ko)
DE (1) DE60226710D1 (ko)
DK (1) DK1372652T3 (ko)
EA (1) EA007815B1 (ko)
ES (1) ES2305253T3 (ko)
HR (1) HRPK20030766B3 (ko)
HU (1) HU229258B1 (ko)
IL (2) IL158058A0 (ko)
ME (1) MEP16408A (ko)
MX (1) MXPA03007743A (ko)
NO (1) NO332441B1 (ko)
NZ (1) NZ527655A (ko)
PE (1) PE20020907A1 (ko)
PL (1) PL206118B1 (ko)
PT (1) PT1372652E (ko)
RS (1) RS50681B (ko)
SI (1) SI1372652T1 (ko)
SK (1) SK287481B6 (ko)
TW (1) TWI355935B (ko)
UY (1) UY27220A1 (ko)
WO (1) WO2002076484A2 (ko)
ZA (1) ZA200307381B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1487434B1 (en) * 2002-03-06 2007-05-09 The Medical Research and Education Trust Botanical extract compositions with anti-cancer activity comprising isoliquiritigenin
AU2003287081A1 (en) * 2002-10-16 2004-05-04 Ilex Products, Inc. Clofarabine and taxane chemotherapy combination
ES2318202T3 (es) * 2002-11-06 2009-05-01 Cyclacel Limited Combinacion que comprende docetaxel y un inhibidor de cdk.
CA2623729A1 (en) * 2006-02-10 2007-08-16 Nerviano Medical Sciences S.R.L. Combinations comprising a cdk inhibitor and a growth factor antibody or anti-mitotic
US20130237582A1 (en) * 2010-11-19 2013-09-12 Piramal Enterprises Limited Pharmaceutical combination of paclitaxel and a cdk inhibitor
BR112013025410A2 (pt) * 2011-04-01 2016-12-20 Astrazeneca Ab tratamento terapêutico
PT2785349T (pt) 2011-11-30 2019-12-11 Astrazeneca Ab Tratamento combinado de cancro
AU2013204533B2 (en) 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
EP0888458A4 (en) * 1996-02-20 2004-05-06 Sloan Kettering Institutefor C COMBINATION OF PROTEIN KINASE C INHIBITORS AND THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER

Also Published As

Publication number Publication date
CA2441441C (en) 2009-05-26
EA200301053A1 (ru) 2004-02-26
YU69503A (sh) 2006-08-17
EA007815B1 (ru) 2007-02-27
US20020182204A1 (en) 2002-12-05
HU229258B1 (en) 2013-10-28
PL206118B1 (pl) 2010-07-30
AU2002312815B2 (en) 2006-08-24
ATE395917T1 (de) 2008-06-15
PE20020907A1 (es) 2002-12-19
NZ527655A (en) 2006-03-31
RS50681B (sr) 2010-06-30
PT1372652E (pt) 2008-07-24
HUP0303589A2 (hu) 2004-03-01
TWI355935B (en) 2012-01-11
CY1110449T1 (el) 2015-04-29
SK11692003A3 (sk) 2004-03-02
EP1372652A2 (en) 2004-01-02
JP2004521140A (ja) 2004-07-15
WO2002076484A2 (en) 2002-10-03
ZA200307381B (en) 2005-03-30
DK1372652T3 (da) 2008-09-22
KR20030086318A (ko) 2003-11-07
PL367702A1 (en) 2005-03-07
NO20034124D0 (no) 2003-09-16
CA2441441A1 (en) 2002-10-03
AR034222A1 (es) 2004-02-04
CZ301423B6 (cs) 2010-02-24
CN1498107A (zh) 2004-05-19
UY27220A1 (es) 2002-09-30
MXPA03007743A (es) 2004-11-12
KR100879712B1 (ko) 2009-01-22
NO332441B1 (no) 2012-09-17
MEP16408A (en) 2010-10-10
WO2002076484A3 (en) 2003-01-03
BR0208221A (pt) 2004-03-02
HRP20030766A2 (en) 2005-06-30
NO20034124L (no) 2003-09-16
SK287481B6 (sk) 2010-11-08
HRPK20030766B3 (en) 2006-11-30
ES2305253T3 (es) 2008-11-01
HUP0303589A3 (en) 2007-05-02
CZ20032551A3 (en) 2004-07-14
DE60226710D1 (de) 2008-07-03
SI1372652T1 (sl) 2008-10-31
EP1372652B1 (en) 2008-05-21
IL158058A (en) 2010-02-17
US20060128640A1 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
MXPA03006420A (es) Diaminotiazoles.
EP1383743A4 (en) DOUBLE INHIBITORS OF PDE 7 AND PDE 4
EP1363702A4 (en) PROCESS FOR INHIBITING KINASES
HK1061854A1 (en) Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
AU3704101A (en) Kinase inhibitors
GB0025782D0 (en) Use of inhibitors
EP1390052A4 (en) INHIBITION OF JUN KINASE
PL369742A1 (en) Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
HUP0303589A3 (en) Combination of a taxane and a cyclin-dependent kinase inhibitor
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
GB0101686D0 (en) Cyclin dependent kinase inhibitors
EP1467978A4 (en) "COMPOUNDS THAT CONTAIN VACCINATES DRUG LIPASE, THEIR SYNTHESIS AND USE"
IL154927A0 (en) Combination of statins and sorbitol dehydrogenase inhibitors
MXPA03006423A (es) Naftostirilos.
IL160230A0 (en) Use of il-18 inhibitors
IL161608A0 (en) Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines
IL156839A0 (en) Use of chromanes
ZA200305379B (en) Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase.
GB0126214D0 (en) Inhibition of hyperproliferation
GB2394953B (en) Inhibition of replication factor C
HU0104370D0 (en) Honeyed schnaps of oerseg
CA91419S (en) A set of furniture
AU145954S (en) A set of cases
AU145953S (en) A set of cases
CA91421S (en) Set of furniture